| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/04/2002 | WO2002026214A1 Ion-strength independent sustained release pharmaceutical formulation |
| 04/04/2002 | WO2002026020A2 Tricyclic antidepressants and their analogues as long-acting local anesthetics and analgesics |
| 04/04/2002 | WO2002014281A8 Pyridine derivatives as inhibitors of p38 |
| 04/04/2002 | WO2002000662B1 Improvements in and relating to chromophores |
| 04/04/2002 | WO2002000167A3 Modified forms of pharmacologically active agents and uses therefor |
| 04/04/2002 | WO2001098266A3 N-and o-substituted 4-[2-(diphenylmethoxy)-ethyl]-1-[(phenyl)methyl]piperidine analogs and methods of treating cns disorders therewith |
| 04/04/2002 | WO2001097837A8 Solubilised protein vaccines |
| 04/04/2002 | WO2001097795A3 Systems and methods for treating a mucosal surface |
| 04/04/2002 | WO2001093893A3 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy |
| 04/04/2002 | WO2001089451A3 Protease inhibitors |
| 04/04/2002 | WO2001085980A3 Enzymatic assays for screening anti-cancer agents |
| 04/04/2002 | WO2001082954A3 Ceruloplasmin and uses thereof in neurodegenerative related conditions |
| 04/04/2002 | WO2001074815A3 Phenyl-substituted imidazopyridines |
| 04/04/2002 | WO2001074773A3 Phenyl-substituted indoles as histamine h3-receptor antagonists |
| 04/04/2002 | WO2001073034A3 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 04/04/2002 | WO2001072839A3 Human g-protein coupled receptors |
| 04/04/2002 | WO2001064896A3 Human enzyme molecules |
| 04/04/2002 | WO2001062799A3 Method for inhibiting angiogenesis using molecules that enhance plasmin activity |
| 04/04/2002 | WO2001060375A3 Use of 7alpha-hydroxy-estradiol, 7alpha-hydroxy-dehydroepiandrosterone and 7alpha-hydroxy-pregnenolone derivatives for treating acute cellular degeneration |
| 04/04/2002 | WO2001053353A3 Recombinant antibodies to human interkleukin-1 beta |
| 04/04/2002 | WO2001050848A3 Clonal propagation of primate offspring by embryo splitting |
| 04/04/2002 | WO2001049715A3 Methods and compositions for inhibiting neoplastic cell growth |
| 04/04/2002 | WO2001044197A3 2-phenyl-quinoline derivatives and their use as contracting agent for smooth muscles |
| 04/04/2002 | WO2000070099A3 Differential gene expression in specific regions of the brain in neurodegenerative diseases |
| 04/04/2002 | WO2000058359A9 Retro-inverso prosaposin-derived peptides and use thereof |
| 04/04/2002 | WO2000048549A3 Anticonvulsant derivatives useful in treating essential tremor |
| 04/04/2002 | US20020040484 Administering to cell a compound capable of modulating protein complex having a first protein which is delta -catenin interacting with a second protein which is FAK2 |
| 04/04/2002 | US20020040205 Method and apparatus for transcutaneous infusion of carbon dioxide for local relief of pain and other ailments |
| 04/04/2002 | US20020040164 For use in anxiolytic agents |
| 04/04/2002 | US20020040153 Reductive hydrolysis of 5-(amido)-1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)1,3-dihy -droisobenzofuran to form 5-formyl-derivative; converting to citalopram |
| 04/04/2002 | US20020040150 Skin treatment compositons containing a cationic polymer and a microparticle or nanoparticle vector |
| 04/04/2002 | US20020040146 Useful as inhibitors of metalloproteases, e.g. zinc proteases, and which are effective in therapy of disease states associated with vasoconstriction |
| 04/04/2002 | US20020040060 2'-methyl-biphenyl-2-carboxylic acid-(3,5-bis-trifluoromethyl-benzyl)-methyl-amide, for example; treating disease related to neurokinin 1 receptor |
| 04/04/2002 | US20020040052 By administering a poyalkoxyflavonoid having a specific structure, especially nobiletin or tangeretin; plant extract from citrus family |
| 04/04/2002 | US20020040048 (2S,4R)-4-Mercapto-1-(naphthalene-2-sulfonyl)-pyrrolidine-2 -carboxylic acid N'-isobutyl-N'-(4-methyl-benzenesulfonyl)-hydrazide, for example; inhibitors of metalloproteases, e.g. zinc proteases; vasodilators |
| 04/04/2002 | US20020040040 N-(3,5-bis-trifluoromethyl-benzyl)-6-(4-hydroxyacetyl-piperazin-1 -yl)-N-methyl-4-o-tolyl-nicotinamide, for example |
| 04/04/2002 | US20020040038 Administering donepezil or its hydrochloride salt |
| 04/04/2002 | US20020040037 Prodrug acid esters of [2-(4-benzyl-3-hydroxy-piperidin-1-yl)-ethansulfonyl]phenol |
| 04/04/2002 | US20020040036 1-(4-bromophenyl)-2-(1-methyl-2-piperidinyl)-1-ethanone, for example; treating neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, Korsakoff's disease and frontal lobe and subcortical dementias |
| 04/04/2002 | US20020040035 Quinuclidine-substituted aryl compounds for treatment of disease |
| 04/04/2002 | US20020040026 Phenyloxy-and phenylthiosubstituted pyrimidines and triazines and derivatives useful for treating anxiety, depression, effective disorders, post-traumatic stress disorders etc. |
| 04/04/2002 | US20020040025 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof |
| 04/04/2002 | US20020040024 A phenoxy substituted piperidine derivative, useful for treating or preventing histamine H3 receptor activity |
| 04/04/2002 | US20020040016 Derivatives of azetidine and pyrrolidine |
| 04/04/2002 | US20020040013 Novel therapeutic use of low molecular weight heparins |
| 04/04/2002 | US20020040000 Human kcnq5 potassium channel, methods and compositions thereof |
| 04/04/2002 | US20020039789 Method for production of neuroblasts |
| 04/04/2002 | US20020039736 Reacting aliphatic aminonitrile with water in presence of solid alumina catalyst to form lactam |
| 04/04/2002 | US20020039724 Neural progenitor cell populations |
| 04/04/2002 | US20020039599 Calibration; administering antiseptic compound |
| 04/04/2002 | US20020039577 Methods for regulating a lymphocyte-mediated immune response by blocking costimulatory signals and blocking LFA-1 mediated adhesion in lymphocytes |
| 04/04/2002 | US20020039575 Supplying polypepties |
| 04/04/2002 | US20020039560 Drug delivery |
| 04/04/2002 | DE10046838A1 Verwendung von Myxoxanthophyll und/oder Echinenon zur prophylaktischen und/oder therapeutischen Behandlung von unerwünschten, durch oxidative Prozesse bedingten oder begünstigten körperlichen Zuständen Use of Myxoxanthophyll and / or echinenone for prophylactic and / or therapeutic treatment of unwanted situations due to oxidative processes beneficiary physical conditions |
| 04/04/2002 | DE10045845A1 Xenon als Arzneimittel Xenon as medicinal |
| 04/04/2002 | DE10045831A1 Anticonvulsant, anxiolytic and especially analgesic medicaments, comprising new or known beta-thio-alpha-aminoacid compounds having strong affinity for gabapentin binding site |
| 04/04/2002 | DE10044792A1 Substituierte Phenylcyclohexancarbonsäureamide und ihre Verwendung Substituted Phenylcyclohexancarbonsäureamide and their use |
| 04/04/2002 | CA2426666A1 Ion-strength independent sustained release pharmaceutical formulation |
| 04/04/2002 | CA2424949A1 Pharmaceutical oxan preparation |
| 04/04/2002 | CA2424062A1 Primitive neural stem cells and method for differentiation of stem cells to neural cells |
| 04/04/2002 | CA2424021A1 Catecholamine compositions and uses thereof |
| 04/04/2002 | CA2423953A1 Hydrolases |
| 04/04/2002 | CA2423919A1 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
| 04/04/2002 | CA2423903A1 O-substituted 6-methyltramadol derivatives |
| 04/04/2002 | CA2423889A1 Methods and compositions for screening modulators of lipid kinases |
| 04/04/2002 | CA2423805A1 Treatment of immune-mediated diseases by oral administration of plasma fractions enriched in immunoglobulin g |
| 04/04/2002 | CA2423704A1 G-protein coupled receptors |
| 04/04/2002 | CA2423694A1 Transferases |
| 04/04/2002 | CA2423668A1 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 04/04/2002 | CA2423613A1 Transgenic drosophilia melanogaster expressing beta amyloid |
| 04/04/2002 | CA2423449A1 Tricyclic antidepressants and their analogues as long-acting local anesthetics and analgesics |
| 04/04/2002 | CA2423424A1 Secreted proteins |
| 04/04/2002 | CA2423313A1 Methods of treating inflammatory and immune reactions and compositions therefor |
| 04/04/2002 | CA2423305A1 Compounds useful in the treatment of inflammatory diseases |
| 04/04/2002 | CA2423251A1 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 04/04/2002 | CA2423141A1 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 04/04/2002 | CA2421209A1 Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein junkinases |
| 04/04/2002 | CA2420960A1 Potassium channel interactors and uses therefor |
| 04/04/2002 | CA2420475A1 Ige receptor antagonists |
| 04/04/2002 | CA2420045A1 Melanocortin receptor ligands |
| 04/04/2002 | CA2416656A1 Compositions and methods for the endocytic presentation of immunosuppressive factors |
| 04/03/2002 | EP1193268A1 Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein Junkinases |
| 04/03/2002 | EP1193267A1 Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein JunKinases |
| 04/03/2002 | EP1193261A1 New thiadiazoles and their use as phosphodiesterase-7 inhibitors |
| 04/03/2002 | EP1193260A1 Phenoxazine analogs for the treatment of amyloidosis |
| 04/03/2002 | EP1193259A1 Dihydropyrimidine derivatives |
| 04/03/2002 | EP1193256A1 Pharmaceutically active benzsulfonamide derivatives as inhibitors of JNK proteins |
| 04/03/2002 | EP1193250A1 Phenyl sulfamate derivatives |
| 04/03/2002 | EP1193249A1 Citrullimycines, a process for their production and their use as pharmaceuticals |
| 04/03/2002 | EP1192952A2 Combination, for treating depression and anxiety, containing an NK-3 receptor antagonist and a CNS penetrant NK-1 receptor antagonist |
| 04/03/2002 | EP1192951A2 Pharmaceutical composition containing a compound having angiotensin II antagonistic activity in combination with another compound |
| 04/03/2002 | EP1192462A1 Prevention and treatment of amyloid-associated disorders |
| 04/03/2002 | EP1192278A1 48 human secreted proteins |
| 04/03/2002 | EP1192266A2 Complement-resistant non-mammalian dna viruses and uses thereof |
| 04/03/2002 | EP1192261A1 22025, a novel human cyclic nucleotide phosphodiesterase |
| 04/03/2002 | EP1192258A2 Human poly(adp-ribose) polymerase 2 materials and methods |
| 04/03/2002 | EP1192257A2 Human regulators of intracellular phosphorylation |
| 04/03/2002 | EP1192251A1 Human sel-10 polypeptides and polynucleotides that encode them |
| 04/03/2002 | EP1192250A2 Human rna metabolism proteins (rmep) |
| 04/03/2002 | EP1192247A1 Sphingosine kinase enzyme |